We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Donkey discount

24 October 2016 By Rachel Morarjee

CR Pharma is raising $1.8 bln from its Hong Kong IPO. A holding company structure and the rising price of donkey hide, a key ingredient, justify a discount valuation to peers. But a respectable roster of big foreign investors underscores the healthy prognosis for the sector.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)